ENT Solutions
11 Hospital Way
Blairsville, Georgia 30512
706-745-1305 http://www.entsolutions.us.com/ deb@entsolutions.us.com

Use our guide to learn which trials are right for you!

ENT Solutions is a premier ENT/Head and Neck Surgery specialty facility located in Blairsville, GA. We proudly offer cutting-edge electronics for patient information and educational purposes, a variety of services such as hearing tests and hearing aids, allergy testing and treatment with sublingual drops, and ENT clinic services and surgery. Not only are we committed to top-notch ENT clinic care, we are also committed to providing the highest quality Phase II, III, III-B, IV clinical research services to the pharmaceutical industry.

Site specialties:

  • Auditory Diseases
  • Croup
  • Deaf/Blind Disorders
  • Ear Diseases

Center Specialties and Interest:

  • Epistaxis
  • Hearing Loss
  • Hoarseness
  • Laryngeal Diseases
  • Mastoiditis
  • Nasal Obstruction
  • Nasal Polyps
  • Nasopharyngeal Neoplasms
  • Nose Deformities
  • Otitis
  • Otosclerosis
  • Pharyngeal Diseases
  • Rhinitis
  • Sinusitis
  • Surgery-Head & Neck
  • Tonsillitis
  • Vertigo
  • Vestibular Disease
  • Voice Disorders

Wendy L. Smith, MD
Area of Expertise-ENT Diseases/Conditions, Head and Neck Surgeon

Deborah C. Allen, CCRC
Clinical Research Director
14 years clinical research experience
Certified CCRC for 12 years

Studies performed and Pharmaceutical Company worked with:
(Indication Sponsor Year)

  • Pneumonia Rhone-Poulenc Rorer 1994
  • Chronic Bronchitis Rhone-Poulenc Rorer 1994
  • Hypertension with LVH Merck & Co. 1994
  • Hypertension Sanko 1994
  • Chronic Bronchitis Rhone-Poulenc Rorer 1996
  • Pneumonia Rhone-Poulenc Rorer 1996
  • COPD Dey Labs 1996
  • H-Pylori Astra+Merck 1996
  • Hypertension Bristol-Myers 1997
  • COPD SmithKline 1997
  • Heartburn TAP Holdings, Inc. 1997
  • Summer Flu ViroPharma 1997
  • Type II Diabetes SmithKline 1997
  • Dyspepsia TAP Holdings, Inc. 1997
  • Post-MI Proctor & Gamble 1997
  • GERD TAP Holdings, Inc. 1997
  • Catheter-related Bacteremia Rhone-Poulenc Rorer 1997
  • Chronic Bronchitis TAP Holdings, Inc. 1998
  • Summer Flu ViroPharma 1998
  • COPD SmithKline 1998
  • Pneumonia TAP Holdings, Inc. 1998
  • Chronic Bronchitis SmithKline 1999
  • Pneumonia SmithKline 1999
  • Chronic Bronchitis Bristol-Myers 1999
  • COPD Glaxo Wellcome 1999
  • COPD Pfizer 1999
  • Pneumonia Abbott 1999
  • Chronic Bronchitis SmithKline 1999
  • Osteoarthritis Merck & Co. 2000
  • Drug Na%EFve Diabetes SmithKline 2000
  • Irritable Bowel Syndrome Glaxo Wellcome 2000
  • DNA-Healthy Subjects Genomics 2000
  • DNA-Diseased Subjects Genomics 2000
  • In-Patient Pneumonia Bayer 2000
  • Impetigo PharmaKinetics 2000
  • Soft Tissue Infection Cubist Pharmaceuticals 2000
  • Hypertension PPD Development 2000
  • COPD SmithKline 2001
  • Migraine Headache Astrazeneca 2001
  • Pneumonia Bayer 2001
  • Pneumonia Cubist Pharmaceuticals, Inc 2001
  • COPD SmithKline 2001
  • Sinusitis Warner-Lambert 2001
  • Pneumonia Aventis 2001
  • Chronic Bronchitis SmithKline 2001
  • Skin+Skin Structure Infection Eli Lilly 2001
  • Irritable Bowel Syndrome Solvay 2002
  • COPD Abgenix 2002
  • Nursing Home Depression Organon 2002
  • Asthma Aventis 2002
  • Pressure Ulcer Smith & Nephew 2002
  • Sinusitis Advanced Biologics 2002
  • Hyperlipidemia Sanofi-Synthelabo 2002
  • Hypertension Bertek 2002
  • GERD PPD Development 2002
  • Type II Diabetes Astrazeneca 2002
  • Chronic Bronchitis GlaxoSmithKline 2002
  • COPD GlaxoSmithKline 2002
  • Rheumatoid Arthritis Bristol-Myers Squibb 2002
  • Pediatric Pneumonia Johnson & Johnson 2002
  • Pediatric Otitis Media Johnson & Johnson 2002
  • Laparoscopic Cholecystectomy Pharmacia 2002
  • Chronic Bronchitis Paragon Biomedical 2002
  • HTN with Hyperlipidemia Pfizer 2002
  • Gout Pharmacia 2002
  • Cardiac Event Prevention Astrazeneca 2002
  • Type II Diabetes with Insulin Parexel 2002
  • Hypertension Sanofi-Synthelabo 2003
  • Migraine Headache Pfizer 2003
  • Psoriasis Genentech, Inc. 2003
  • Type II Diabetes GlaxoSmithKline 2003
  • COPD Centocor 2003
  • Irritable Bowel Syndrome GlaxoSmithKline 2003
  • Depression Eli Lilly 2003
  • Osteoarthritis of Knee & Hip Grunenthal, Inc. 2004
  • COPD ALTANA Pharma, Inc. 2003
  • Post-Stroke Aventis 2003
  • Chronic Bronchitis Abbott 2003
  • Medabolic Syndrome Sanofi-Synthelabo 2003
  • CAD Prevention Astrazeneca 2003
  • Hypertension Integrium 2003
  • Asthma PPD Development 2003
  • Type II Diabetes GlaxoSmithKline 2003
  • Migraine Headache Access Medical 2003
  • COPD Dey Labs 2004
  • Benign Prostatic Hypertrophy i3 Research 2004
  • Skin Infection Basilea 2004
  • Gout Pfizer 2004
  • Osteoporosis Eli Lilly 2004
  • Osteoarthritis Alza 2004
  • Type II Diabetes Takeda 2004
  • Psoriasis Genentech, Inc. 2005
  • Osteoarthritis Johnson & Johnson 2005
  • COPD Centocor 2004
  • Elevated CRP PPD Development 2004
  • Otitis Media Sanofi-Aventis 2005
  • Metabolic Syndrome Bristol-Myers Squibb 2005
  • Chronic Bronchitis Replidyne, Inc. 2005
  • Hypertension Alteon 2005
  • Type II Diabetes Roche 2005
  • Pneumonia Advanced Life Sciences 2006
  • COPD ALTANA Pharma, Inc. 2006
  • Hypertension Boehringer Ingelheim 2006
  • Atrial Fibrillation Sanofi-Aventis 2006
  • Atrial Fibrillation Boehringer Ingelheim 2006
  • Heartburn on NSAIDS Pfizer 2006
  • Heartburn PPD 2007
  • Osteoarthritis of Knee & Hip Alpharma Pharmaceuticals 2007
  • Chronic Pain Alpharma Pharmaceuticals 2007
  • Rheumatoid Arthritis Roche 2008
  • Chronic Kidney Disease Regeneron 2008
  • Osteoarthritis Pain Neuromed 2008
  • COPD Forest Research 2008
  • COPD Forest Research 2008
  • Osteoarthritis of Knee Wyeth 2008
  • Stroke/ A-Fib Sanofi-Aventis 2008
  • Acute Shoulder Pain Hisamitsu 2008
  • Acute Ankle Sprain Hisamitsu 2008
  • Fibromyalgia Eli Lilly 2008
  • Resistant Hypertension Gilead 2008
  • DVT/ VTE/ PE Pfizer-BMS 2008
  • Naïve Diabetes Spherix 2008

  • 97.5% white (caucasian)
  • 0.4% Hispanic/latino
  • 0.2% black
  • 0.3% asian
  • 1.1% multi-racial
  • 0.1% other
  • 50.5% female
  • 49.5% male
  • 10.9% 0-9 years
  • 12.5% 10-19 years
  • 9.4% 20-29 years
  • 12.9% 30-39 years
  • 15.7% 40-49 years
  • 15.2% 50-59 years
  • 12.3% 60-69 years
  • 7.8% 70-79 years
  • 3.5% 80+ years

Immunology/Infectious Diseases
Otolaryngology

ENT Solutions is a state-of-the-art facility located in the north east Georgia mountains. We are located on hospital campus and have 90+ referring physicians. We are an outpatient, ambulatory site. We have community based investigators, certified clinical research staff and a large patient database which allows us to provide quality research with quality patients.


Deborah C. Allen
Research Director
ENT Solutions
11 Hospital Way
Blairsville, GA 30512
USA
706-745-1305
706-745-8463 (fax)
deb@entsolutions.us.com
www.entsolutions.us.com/


We've found
0 trials
at this facility